Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment.
Rizzetto M, Verme G, Recchia S, Bonino F, Farci P, Aricò S, Calzia R, Picciotto A, Colombo M, Popper H.
Ann Intern Med. 1983 Apr;98(4):437-41. doi: 10.7326/0003-4819-98-4-437.
[Chronic active hepatitis].
Viola LA, Fernández J.
Medicina (B Aires). 1986;46(3):359-61.
Chronic active hepatitis.
Kolts BE, Spindel E.
Am Fam Physician. 1984 Jun;29(6):228-43.
Localization of hepatitis B core antigens in chronic active hepatitis using immunoperoxidase and chromotrope aniline blue staining.
Ozeki T, Mizuno S, Sanefuzi H, Tanaka N, Fujiwara H, Masuda H, Funakoshi K.
Br J Exp Pathol. 1987 Oct;68(5):605-12.
Pathogenesis of chronic active hepatitis B.
Thomas H.
J Gastroenterol Hepatol. 1991;6 Suppl 1:4-6. doi: 10.1111/j.1440-1746.1991.tb01157.x.
Interferon-induced chronic active hepatitis?
Silva MO, Reddy KR, Jeffers LJ, Hill M, Schiff ER.
Gastroenterology. 1991 Sep;101(3):840-2. doi: 10.1016/0016-5085(91)90547-x.
Corticosteroid therapy for chronic active hepatitis B: is a little to much?
Perrillo RP, Regenstein FG.
Hepatology. 1986 Nov-Dec;6(6):1416-8. doi: 10.1002/hep.1840060633.
[Chronic active hepatitis with superinfection of delta virus and hepatitis B virus: treatment with Chinese traditional medicine].
Chen NL, Gu F, Jia KM.
Zhonghua Nei Ke Za Zhi. 1990 Mar;29(3):144-6, 189.
A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B.
Nair PV, Tong MJ, Stevenson D, Roskamp D, Boone C.
Hepatology. 1986 Nov-Dec;6(6):1319-24. doi: 10.1002/hep.1840060616.
Efficacy of polyadenylic.polyuridylic acid in the treatment of chronic active hepatitis B.
Hahm KB, Han KY, Kim WH, Yim DS, Chon CY, Moon YM, Kang JK, Park IS, Youn JK, Deschamps de Paillette E.
Int J Immunopharmacol. 1994 Mar;16(3):217-25. doi: 10.1016/0192-0561(94)90015-9.
